# Universal Germline Testing in the Community

> **NCT05416710** · — · UNKNOWN · sponsor: **Invitae Corporation** · enrollment: 1000 (estimated)

## Conditions studied

- Cancer
- Solid Tumor
- Solid Tumor, Adult

## Interventions

- **DIAGNOSTIC_TEST:** Invitae's 84 gene multi-cancer panel.

## Key facts

- **NCT ID:** NCT05416710
- **Lead sponsor:** Invitae Corporation
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** UNKNOWN
- **Start date:** 2022-06-01
- **Primary completion:** 2025-06-01
- **Final completion:** 2025-06-01
- **Target enrollment:** 1000 (ESTIMATED)
- **Last updated:** 2022-12-07


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05416710

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05416710, "Universal Germline Testing in the Community". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT05416710. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*